Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,784 | 1,837 | 1,714 | 6,573 | 17,934 |
| Marketable Securities | 9,832 | 10,538 | 13,036 | 9,914 | N/A |
| Receivables | 25 | 16 | 16 | 45 | 16 |
| TOTAL | $12,044 | $12,783 | $15,129 | $16,888 | $18,324 |
| Non-Current Assets | |||||
| PPE Net | 314 | 304 | 261 | 231 | 267 |
| Intangibles | 759 | 781 | 803 | 530 | 551 |
| Other Non-Current Assets | 184 | 213 | 242 | 271 | 300 |
| TOTAL | $1,256 | $1,298 | $1,306 | $1,032 | $1,117 |
| Total Assets | $13,300 | $14,081 | $16,435 | $17,920 | $19,442 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 276 | 93 | 171 | 469 | 378 |
| Accrued Expenses | 386 | 233 | 130 | 115 | 115 |
| TOTAL | $813 | $470 | $440 | $717 | $622 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 84 | 124 | 162 | 199 | 234 |
| TOTAL | $84 | $124 | $162 | $199 | $234 |
| Total Liabilities | $896 | $594 | $603 | $916 | $856 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,668 | 3,888 | 3,768 | 3,674 | 3,646 |
| Retained earnings | -161,306 | -158,325 | -152,641 | -148,293 | -143,638 |
| Other shareholders' equity | 14 | 15 | 15 | 15 | 15 |
| TOTAL | $12,404 | $13,487 | $15,832 | $17,004 | $18,586 |
| Total Liabilities And Equity | $13,300 | $14,081 | $16,435 | $17,920 | $19,441 |